Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
Autor: | Jorrit De Waele, Marc Peeters, Evelien Smits, Filip Lardon, Jan B Vermorken, Julie Jacobs, Hasan Baysal, An Wouters, Patrick Pauwels, Hannah Zaryouh, Ines De Pauw |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Cancer Research
Cell Cetuximab chemical and pharmacologic phenomena Innate lymphoid cells Cell Growth Processes Article Natural killer cell 03 medical and health sciences 0302 clinical medicine Targeted therapies Antineoplastic Agents Immunological Cell Line Tumor Medicine Humans Epidermal growth factor receptor Cytotoxicity Head and neck cancer neoplasms Papillomaviridae 030304 developmental biology Antibody-dependent cell-mediated cytotoxicity 0303 health sciences biology business.industry Squamous Cell Carcinoma of Head and Neck Papillomavirus Infections Antibody-Dependent Cell Cytotoxicity medicine.disease Head and neck squamous-cell carcinoma digestive system diseases ErbB Receptors Killer Cells Natural Cancer therapeutic resistance medicine.anatomical_structure Oncology Head and Neck Neoplasms 030220 oncology & carcinogenesis biology.protein Cancer research Human medicine Antibody business medicine.drug |
Zdroj: | British Journal of Cancer The British journal of cancer |
ISSN: | 1532-1827 0007-0920 |
Popis: | Background The epidermal growth factor receptor (EGFR) is overexpressed by 80–90% of squamous cell carcinoma of head and neck (HNSCC). In addition to inhibiting EGFR signal transduction, cetuximab, a monoclonal antibody targeting EGFR can also bind to fragment crystallisable domain of immunoglobulins G1 present on natural killer (NK), causing antibody-dependent cellular cytotoxicity (ADCC). However, presence of cetuximab resistance limits effective clinical management of HNSCC. Methods In this study, differences in induction of ADCC were investigated in a panel of ten HNSCC cell lines. Tumour cells were co-cultured with NK cells and monitored using the xCELLigence RTCA. Results While ADCC was not influenced by HPV status, hypoxia and cetuximab resistance did affect ADCC differentially. Intrinsic cetuximab-resistant cell lines showed an increased ADCC induction, whereas exposure to hypoxia reduced ADCC. Baseline EGFR expression was not correlated with ADCC. In contrast, EGFR internalisation following cetuximab treatment was positively correlated with ADCC. Conclusion These findings support the possibility that resistance against cetuximab can be overcome by NK cell-based immune reactions. As such, it provides an incentive to combine cetuximab with immunotherapeutic approaches, thereby possibly enhancing the anti-tumoural immune responses and achieving greater clinical effectiveness of EGFR-targeting agents. |
Databáze: | OpenAIRE |
Externí odkaz: |